This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland
The drug ENDOLUCINBETA contains one active pharmaceutical ingredient (API):
|
1
Lutetium ¹⁷⁷Lu chloride
UNII 1U477369SN - LUTETIUM CHLORIDE LU-177
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V10XX | Various therapeutic radiopharmaceuticals | V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1725780, 1725791 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61773428 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 044953014, 044953026 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080756, 1080757 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100382978 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
